Changjiang Pharmaceutical Group Co., Ltd. (SHE:300391)
China · Delayed Price · Currency is CNY 0.9200
+0.1500 (19.48%)
At close: Jan 23, 2026
SHE:300391 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -656.72 | -627.96 | -605.65 | -23.27 | 49.1 | 25.32 |
Depreciation & Amortization | 37.22 | 37.22 | 46.46 | 115.28 | 59.61 | 42.98 |
Other Amortization | 0.16 | 0.16 | 0.36 | 16.38 | 6.68 | 8.53 |
Loss (Gain) From Sale of Assets | 0.3 | 0.3 | -0.08 | - | -2.1 | 3.33 |
Asset Writedown & Restructuring Costs | 450.23 | 450.23 | 537.56 | 33.21 | 16 | 0.03 |
Loss (Gain) From Sale of Investments | 4.39 | 4.39 | -67.63 | -55.19 | -0 | 2.46 |
Provision & Write-off of Bad Debts | 627.96 | 627.96 | 193.69 | 78.34 | 45.74 | -4.05 |
Other Operating Activities | -764.5 | -691.98 | -15.97 | 120.87 | 175.27 | 72.69 |
Change in Accounts Receivable | 313.44 | 313.44 | -510.54 | 113.98 | -153.15 | -39.06 |
Change in Inventory | 10.78 | 10.78 | -4.71 | 135.87 | 50.84 | -56.77 |
Change in Accounts Payable | -210.81 | -210.81 | 255.75 | -628.79 | -1.53 | -7.38 |
Operating Cash Flow | -176.58 | -75.3 | -147.43 | -66.08 | 230.99 | 32.81 |
Operating Cash Flow Growth | - | - | - | - | 604.11% | 47.10% |
Capital Expenditures | 1.32 | -4.21 | -6.79 | -51.47 | -142.26 | -18.82 |
Sale of Property, Plant & Equipment | 0.05 | 0.02 | 0.08 | - | 13.01 | 1.91 |
Cash Acquisitions | - | - | - | - | -1,044 | -86.86 |
Divestitures | - | - | - | - | 95 | -56.61 |
Investment in Securities | - | - | - | - | 0.5 | -0.5 |
Other Investing Activities | 0.66 | -6.33 | 71.17 | -10.95 | 623.28 | 0 |
Investing Cash Flow | 2.03 | -10.52 | 64.45 | -62.42 | -454.02 | -160.88 |
Long-Term Debt Issued | - | 258.5 | 424.98 | 563.17 | 835.99 | 311.77 |
Total Debt Issued | 216.99 | 258.5 | 424.98 | 563.17 | 835.99 | 311.77 |
Long-Term Debt Repaid | - | -137.34 | -285.21 | -449.56 | -599.08 | -308.95 |
Total Debt Repaid | -193.24 | -137.34 | -285.21 | -449.56 | -599.08 | -308.95 |
Net Debt Issued (Repaid) | 23.75 | 121.15 | 139.77 | 113.61 | 236.91 | 2.82 |
Common Dividends Paid | -19.36 | -36.22 | -62.04 | - | -37.34 | -12.91 |
Other Financing Activities | 181.93 | - | - | -56.03 | - | - |
Financing Cash Flow | 186.31 | 84.93 | 77.73 | 57.58 | 199.58 | -10.09 |
Foreign Exchange Rate Adjustments | -0.02 | - | - | -0.01 | -0.97 | -15.73 |
Net Cash Flow | 11.74 | -0.9 | -5.24 | -70.93 | -24.43 | -153.89 |
Free Cash Flow | -175.26 | -79.51 | -154.22 | -117.55 | 88.72 | 13.98 |
Free Cash Flow Growth | - | - | - | - | 534.44% | -18.05% |
Free Cash Flow Margin | -150.99% | -71.23% | -12.88% | -7.28% | 3.76% | 1.15% |
Free Cash Flow Per Share | -0.50 | -0.23 | -0.44 | -0.34 | 0.25 | 0.04 |
Cash Interest Paid | - | - | - | 56.03 | - | - |
Cash Income Tax Paid | 2.54 | 7.79 | 12.9 | 4.84 | 19.24 | 5.18 |
Levered Free Cash Flow | 650.8 | 468.08 | -156.26 | -301.53 | -397.38 | 243.33 |
Unlevered Free Cash Flow | 700.72 | 537.56 | -117.94 | -266.51 | -373.67 | 253.06 |
Change in Working Capital | 124.36 | 124.36 | -236.17 | -351.7 | -119.32 | -118.5 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.